APOE genotyping and response to drug treatment in Alzheimer's disease

被引：64

作者：

Richard, F

Helbecque, N

Neuman, E

Guez, D

Levy, R

Amouyel, P

机构：

[1] INST PASTEUR,INSERM,CJF 9505,F-59019 LILLE,FRANCE

[2] INST RECH INT SERVIER,F-92415 COURBEVOIE,FRANCE

[3] INST PSYCHIAT,OLD AGE PSYCHIAT SECT,LONDON SE5 8AF,ENGLAND

来源：

LANCET | 1997年 / 349卷 / 9051期

关键词：

D O I：

10.1016/S0140-6736(97)80089-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：539 / 539

页数：1

共 5 条

[1]

ALLAIN H, 1996, JA M GERIATR SOC, V45, P125

[2]

GUEZ D, 1995, DEV DEMENTIA FUNCTIO, P69

[3]

*NAT I AG ALZH ASS, 1996, LANCET, V347, P1091

[4] Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease [J].

Poirier, J ;

Delisle, MC ;

Quirion, R ;

Aubert, I ;

Farlow, M ;

Lahiri, D ;

Hui, S ;

Bertrand, P ;

Nalbantoglu, J ;

Gilfix, BM ;

Gauthier, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12260-12264

[5] Impact on management of new diagnostic tests in Alzheimer's disease [J].

vanGool, WA ;

vanCrevel, H .

LANCET, 1996, 348 (9032) :961-961

← 1 →